These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 13565816)

  • 1. [Glycocyaminuria in normal and myodystrophic children; its significance in the metabolic disorder of progressive muscular dystrophy].
    SVILOKOS N; SERAFINI L; VERDURA G
    Minerva Pediatr; 1958 May; 10(19-20):549-52. PubMed ID: 13565816
    [No Abstract]   [Full Text] [Related]  

  • 2. [Isonicotinic acid hydrazide therapy of progressive muscular dystrophy in children].
    KUBERSKI Z; SULAT H
    Pediatr Pol; 1956 Aug; 31(8):867-73. PubMed ID: 13400541
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of transmethylating factors on hyperglycocyaminuria of progressive muscular dystrophy].
    VERDURA G; SVILOKOS N; SERAFINI L
    Minerva Pediatr; 1959 Mar; 11(11):302-3. PubMed ID: 13656828
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of pseudo-hypertrophic progressive muscular dystrophy].
    MATOS J; GUERENDIAIN JM
    Acta Pediatr Esp; 1955 Feb; 13(146):140-2. PubMed ID: 14375952
    [No Abstract]   [Full Text] [Related]  

  • 5. [Development in infant and childhood progressive muscular dystrophy].
    Arita M; Matsuda H; Miyano M
    Jinrui Idengaku Zasshi; 1974 Jun; 19(1):111. PubMed ID: 4476826
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac involvement in Fukuyama-type congenital muscular dystrophy.
    Nakanishi T; Sakauchi M; Kaneda Y; Tomimatsu H; Saito K; Nakazawa M; Osawa M
    Pediatrics; 2006 Jun; 117(6):e1187-92. PubMed ID: 16717122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiac problems in patients with progressive muscular dystrophy].
    Danzig V; Fiksa J; Hani AB; Havlová M; Sonka K
    Sb Lek; 2003; 104(3):273-8. PubMed ID: 15224533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain MRI abnormalities in muscular dystrophy due to FKRP mutations.
    Quijano-Roy S; Martí-Carrera I; Makri S; Mayer M; Maugenre S; Richard P; Berard C; Viollet L; Leheup B; Guicheney P; Pinard JM; Estournet B; Carlier RY
    Brain Dev; 2006 May; 28(4):232-42. PubMed ID: 16368217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
    Taniguchi M; Kurahashi H; Noguchi S; Sese J; Okinaga T; Tsukahara T; Guicheney P; Ozono K; Nishino I; Morishita S; Toda T
    Biochem Biophys Res Commun; 2006 Apr; 342(2):489-502. PubMed ID: 16487936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intelligence and education of children with progressive muscular dystrophy].
    Kikuchi K
    Kango Gijutsu; 1971 Mar; 17(3):29-36. PubMed ID: 5205322
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current status and policies of education of children with progressive muscular dystrophy].
    Idogawa S
    Kango Gijutsu; 1971 Mar; 17(3):100-7. PubMed ID: 5205318
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessing functional outcomes of children with muscular dystrophy and scoliosis: the Muscular Dystrophy Spine Questionnaire.
    Wright JG; Smith PL; Owen JL; Fehlings D
    J Pediatr Orthop; 2008 Dec; 28(8):840-5. PubMed ID: 19034175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Growth and development of hospitalized children with severe handicaps. A study of children with progressive muscular dystrophy].
    Arai N
    Kangogaku Zasshi; 1975 Sep; 39(9):892-5. PubMed ID: 127869
    [No Abstract]   [Full Text] [Related]  

  • 14. [AMINOACIDURIA IN PROGRESSIVE MUSCULAR DYSTROPHY].
    GANDULLIA E; GAIERO G
    Minerva Pediatr; 1963 Jun; 15():731-4. PubMed ID: 14060514
    [No Abstract]   [Full Text] [Related]  

  • 15. Intramuscular renin-angiotensin system is activated in human muscular dystrophy.
    Sun G; Haginoya K; Dai H; Chiba Y; Uematsu M; Hino-Fukuyo N; Onuma A; Iinuma K; Tsuchiya S
    J Neurol Sci; 2009 May; 280(1-2):40-8. PubMed ID: 19232644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral health considerations in muscular dystrophies.
    Balasubramaniam R; Sollecito TP; Stoopler ET
    Spec Care Dentist; 2008; 28(6):243-53. PubMed ID: 19068065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of pyruvemia in progressive muscular dystrophy].
    LUZZATTO A; LODIGIANI E
    Minerva Med; 1954 Oct; 45(81):879-86. PubMed ID: 13213786
    [No Abstract]   [Full Text] [Related]  

  • 18. Disturbed gastrointestinal motility; an unusual manifestation of a systemic muscular disorder: polymyositis or progressive muscular dystrophy.
    PATTERSON M; RIOS G
    Gastroenterology; 1959 Feb; 36(2):261-8. PubMed ID: 13620040
    [No Abstract]   [Full Text] [Related]  

  • 19. Health care utilization and expenditures for children and young adults with muscular dystrophy in a privately insured population.
    Ouyang L; Grosse SD; Kenneson A
    J Child Neurol; 2008 Aug; 23(8):883-8. PubMed ID: 18403582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical aspect, pathogenesis and therapy of muscular dystrophies].
    FUTER DS; SERGEICHUK EV
    Pediatriia; 1954; 2():55-60. PubMed ID: 13166487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.